The TCF3/PBX1 fusion oncogene (two transactivation domains of TCF3 fused to the C-terminal portion of PBX1) is under the control of lymphoid-specific promoter/enhancer elements in the pLIT3 expression vector, that include sequences from the proximal promoter of the Lck gene, immunoglobulin enhancer elements, and a TCR Vbeta promoter. The human growth hormone gene with a frameshift mutation in the coding region was inserted 3' of the transgene cDNA to provide introns that enhance the expression. Western blot analysis confirmed expression of the fusion protein in the bone marrow, spleen, and thymus. (J:95693)
查看原文 参与反馈

基础信息

模型ID
品系来源
等位基因类型
突变
遗传方式
基因表达
相关疾病
参考文献
(C57BL/6J x C3H)F2
--
Insertion
--
2
--
3

表型特征

标签摘要:
hm: 纯合子
ht: 杂合子
cn: 条件基因型
cx: 复合型:涉及多基因组
tg: 转基因
ot: 其他:半合子、不确定...
(F): 雌性
(M): 雄性
观察到的表型
N: 正常表型
(#): 上标括号内为相关疾病数量
模型表型:
显示/隐藏列
表型

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top